In short. Profhilo explained as an injectable hyaluronic acid (HA) skin booster: substance class, mechanism, indication range, duration class, and the side-effect profile of bio-remodelling HA injections.
Key points
- Profhilo sits in the skin-quality tier of the injectable ladder, alongside other low-crosslinked HA skin boosters.
- It is not a substitute for volumising HA fillers or for biostimulators; it complements them.
- The realistic role is gradual improvement in skin hydration, elasticity, and fine-line appearance, achieved through a small number of strategically placed injections that spread through the tissue.
Profhilo is an injectable hyaluronic acid (HA) skin booster positioned in a different category from volumising HA fillers. It uses a highly pure, low-crosslinked HA at relatively high concentration, designed to spread through the skin’s tissue planes and stimulate bio-remodelling rather than sit as a discrete filler bead. The result is gradual skin-quality improvement: hydration, elasticity, and a softer overall texture rather than volume or contour change.
Substance class: low-crosslinked hyaluronic acid skin booster
Profhilo uses hyaluronic acid that is minimally crosslinked, which gives it a thin, highly spreadable gel characteristic. Unlike volumising HA fillers that sit as a defined structure under the skin, skin boosters like Profhilo are designed to integrate with the skin tissue and spread through the superficial and deep dermis. The HA itself attracts water and is eventually broken down, but the temporary presence in the skin triggers a bio-remodelling response that improves skin quality over weeks to months.
Common indication range
Profhilo and similar injectable HA skin boosters are used for skin-quality work on the face, neck, décolletage, and hands: hydration, fine-line softening, laxity improvement in selected areas, and overall skin radiance. They are not used for volume restoration, deep contour, or lip enhancement — volumising HA fillers serve those roles. The role of a skin booster is skin health, not facial structure.
How a treatment session is planned
Treatment begins with assessment of skin quality, laxity, hydration, and the patient’s goals. A qualified medical practitioner selects a specific injection protocol (commonly a five-point protocol on each side of the face), plans conservative placement into the deep dermis or subcutaneous layer, and uses review at intervals over weeks to evaluate the gradual response. Typically two sessions a month apart are the starting plan, with maintenance sessions at intervals thereafter.
Expected duration class
Injectable HA skin boosters are temporary. Across the class, the bio-remodelling effect is most visible in the weeks following treatment and gradually fades over a few months, with maintenance sessions typically every few months for sustained skin-quality benefit. Honest counselling avoids fixed month-count promises; the duration of visible skin-quality improvement depends on skin baseline, age, area treated, and individual response.
Where Profhilo fits
Profhilo sits in the skin-quality tier of the injectable ladder, alongside other low-crosslinked HA skin boosters. It is not a substitute for volumising HA fillers or for biostimulators; it complements them. The realistic role is gradual improvement in skin hydration, elasticity, and fine-line appearance, achieved through a small number of strategically placed injections that spread through the tissue.
Side effects and safety considerations
Common temporary effects include small bumps at injection sites that settle within hours to a day or two, plus bruising, swelling, and tenderness. Because the HA is highly pure and low-crosslinked, allergic reactions are rare. Vascular occlusion risk exists with any facial injection and must be managed with anatomical awareness; the reversibility of HA with hyaluronidase remains a meaningful safety feature of the entire HA class, including skin boosters.
Who should defer or avoid
Treatment is generally deferred during pregnancy and breastfeeding, in the presence of active infection or inflammation at the planned injection site, and in patients with bleeding disorders or unrealistic expectations. Patients with autoimmune conditions affecting the skin warrant individual assessment.
Setting realistic expectations
Injectable HA skin boosters improve skin quality gradually over weeks, not instantly. The realistic commitment is a small number of sessions a month apart, with maintenance every few months, and the expectation of subtle rather than dramatic change — softer, more hydrated, more elastic skin, not a different face. They are an investment in skin health, not a substitute for fillers or surgery.
Seek urgent medical review if
- Severe pain, blanching, or a mottled purple pattern appears during or after treatment — possible vascular occlusion requiring immediate hyaluronidase.
- Visual change of any kind occurs during or after facial treatment — emergency ophthalmology must be involved without delay.
- Persistent redness, swelling, or nodule formation develops after treatment — assessment rather than watchful waiting.
Frequently asked questions
How is a skin booster different from a volumising filler?
A skin booster is designed to spread through the tissue and stimulate bio-remodelling rather than sit as a discrete bead. The result is gradual improvement in hydration, elasticity and texture, which is skin quality rather than volume, contour or lip enhancement.
How many sessions are needed, and how often?
Typically two sessions a month apart are the starting plan, with maintenance sessions at intervals afterwards. The effect is most visible in the weeks after treatment and gradually fades over a few months, so honest counselling avoids fixed month-count promises.
What happens to the injection sites afterwards?
Small bumps at injection sites that settle within hours to a day or two, plus bruising, swelling and tenderness. Because the hyaluronic acid is highly pure and low-crosslinked, allergic reactions are rare, and the class remains reversible with hyaluronidase.
Risks & Limitations
- Burns and blistering if settings do not match the skin.
- Post-inflammatory hyperpigmentation, particularly in darker skin types, which may take months to settle.
- Hypopigmentation (lightening) of treated skin, which can be permanent.
- Scarring, including hypertrophic scarring, which is uncommon but real.
- Infection, including reactivation of herpes simplex after resurfacing.
- Acne or milia flare during recovery.
- Results are incremental and most concerns need several sessions. Melasma may rebound or worsen with aggressive treatment.
When to Seek Care
- Blistering, weeping or broken skin beyond the expected reaction.
- Severe pain that is worsening rather than settling.
- Spreading redness, warmth, pus or fever.
- New darkening or firmness that looks like scarring at the treated area.
- Any change in a treated pigmented lesion — it should be reviewed, not retreated.
References & Further Reading
- American Academy of Dermatology (AAD) — laser and energy device information
- American Society for Laser Medicine & Surgery (ASLMS)
- National Medical Products Administration (NMPA, China) — device registration status
- Cochrane Library — systematic reviews in laser dermatology
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.